Health effects of the New Nordic Renal Diet in patients with stage 3 and 4 chronic kidney disease, compared with habitual diet: a randomized trial

被引:9
作者
Hansen, Nikita Misella [1 ,2 ]
Kamper, Anne-Lise [1 ]
Rix, Marianne [1 ]
Feldt-Rasmussen, Bo [1 ,2 ]
Leipziger, Jens [3 ]
Orensen, Mads Vaarby S. [3 ]
Berg, Peder [3 ]
Astrup, Arne [4 ]
Salomo, Louise [1 ]
机构
[1] Copenhagen Univ Hosp, Dept Nephrol, Rigshosp, Copenhagen, Denmark
[2] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
[3] Aarhus Univ, Dept Biomed, Aarhus, Denmark
[4] Novo Nordisk Fdn, Dept Obes & Nutr Sci, Hellerup, Denmark
关键词
chronic kidney disease; New Nordic Renal Diet; dietary intervention; 24h urine phosphorus; low dietary sodium; low dietary protein; proteinuria; acid base; blood pressure; weight loss; metabolic syndrome; GROWTH-FACTOR; 23; WAIST CIRCUMFERENCE; MEDITERRANEAN DIET; PHOSPHATE; FGF23; HYPERPHOSPHATEMIA; PHOSPHORUS; ENERGY; CKD; METAANALYSIS;
D O I
10.1016/j.ajcnut.2023.08.008
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Chronic kidney disease (CKD) leads to an accumulation of waste products and causes adverse cardiometabolic effects. Objectives: We investigated the health effects of the New Nordic Renal Diet (NNRD), a novel meal pattern reduced in phosphorus, protein, and sodium. Methods: A 26-wk randomized trial compared the NNRD with a habitual diet. The NNRD group received weekly home deliveries of food and recipes. Monthly study visits included fasting blood samples, 24-h urine samples, blood pressure, and anthropometric measurements. Intention-to-treat analysis used linear mixed-effects models. Results: Sixty patients, mean estimated glomerular filtration rate (eGFR) 34 mL/min/1.73 m(2) and body mass index of 25-27 kg/m(2), were included and 58 completed. Metabolic syndrome was present in 53% (NNRD group) and 57% (control group). The NNRD group (n = 30) reduced their 24-h urine phosphorus excretion by 19% (-153 mg; 95% confidence interval [CI]: -210, -95), control group (n = 30) (no change), between-group difference -171 mg (95% CI: -233, -109; P < 0.001). Proteinuria was reduced by 39% in the NNRD group (-0.33 g/d; 95% CI: -0.47, -0.18), control group (no change), between-group difference -0.34 g/d (95% CI: -0.52, -0.17; P < 0.001). Plasma urea was reduced by -1.5 mmol/L in the NNRD group (95% CI: -2.1, -0.9), control group (no change), between-group difference -1.4 mmol/L (95% CI: -2.0, -0.7; P < 0.001). Systolic blood pressure fell by -5.2 mmHg in the NNRD group (95% CI: -8.4, -2.1), control group (no change), between-group difference -3.9 mmHg (95% CI; -7.6, -0.2; P = 0.04). The NNRD group lost -1.7 kg (95% CI: -2.6, -0.8), control group (no change), between-group difference -2.0 kg (95% CI: -3.0, -1.0; P < 0.001). There were no effects on eGFR during the 26-wk intervention. Conclusion: NNRD in moderate CKD reduces phosphorus excretion, proteinuria, systolic blood pressure, and weight, mainly by reducing abdominal fat.
引用
收藏
页码:1042 / 1054
页数:13
相关论文
共 71 条
[21]  
Ikizler TA, 2020, AM J KIDNEY DIS, V76, pS11
[22]   PHYTASE ACTIVITY IN THE HUMAN AND RAT SMALL-INTESTINE [J].
IQBAL, TH ;
LEWIS, KO ;
COOPER, BT .
GUT, 1994, 35 (09) :1233-1236
[23]   Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease [J].
Isakova, Tamara ;
Xie, Huiliang ;
Yang, Wei ;
Xie, Dawei ;
Anderson, Amanda Hyre ;
Scialla, Julia ;
Wahl, Patricia ;
Gutierrez, Orlando M. ;
Steigerwalt, Susan ;
He, Jiang ;
Schwartz, Stanley ;
Lo, Joan ;
Ojo, Akinlolu ;
Sondheimer, James ;
Hsu, Chi-yuan ;
Lash, James ;
Leonard, Mary ;
Kusek, John W. ;
Feldman, Harold I. ;
Wolf, Myles .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (23) :2432-2439
[24]   Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease [J].
Isakova, Tamara ;
Wahl, Patricia ;
Vargas, Gabriela S. ;
Gutierrez, Orlando M. ;
Scialla, Julia ;
Xie, Huiliang ;
Appleby, Dina ;
Nessel, Lisa ;
Bellovich, Keith ;
Chen, Jing ;
Hamm, Lee ;
Gadegbeku, Crystal ;
Horwitz, Edward ;
Townsend, Raymond R. ;
Anderson, Cheryl A. M. ;
Lash, James P. ;
Hsu, Chi-yuan ;
Leonard, Mary B. ;
Wolf, Myles .
KIDNEY INTERNATIONAL, 2011, 79 (12) :1370-1378
[25]  
Joshi A., 2015, British journal of applied science & technology, V7, P396, DOI [10.9734/BJAST/2015/14975, DOI 10.9734/BJAST/2015/14975]
[26]   Plant-Based Diets and Hypertension [J].
Joshi, Shivam ;
Ettinger, Leigh ;
Liebman, Scott E. .
AMERICAN JOURNAL OF LIFESTYLE MEDICINE, 2020, 14 (04) :397-405
[27]  
Kalantar-Zadeh K, 2017, NEW ENGL J MED, V377, P1765, DOI [10.1056/NEJMra1700312, 10.1056/nejmra1700312]
[28]   North American experience with Low protein diet for Non-dialysis-dependent chronic kidney disease [J].
Kalantar-Zadeh, Kamyar ;
Moore, Linda W. ;
Tortorici, Amanda R. ;
Chou, Jason A. ;
St-Jules, David E. ;
Aoun, Arianna ;
Rojas-Bautista, Vanessa ;
Tschida, Annelle K. ;
Rhee, Connie M. ;
Shah, Anuja A. ;
Crowley, Susan ;
Vassalotti, Joseph A. ;
Kovesdy, Csaba P. .
BMC NEPHROLOGY, 2016, 17
[29]   Dual-Energy X-Ray Absorptiometry for Quantification of Visceral Fat [J].
Kaul, Sanjiv ;
Rothney, Megan P. ;
Peters, Dawn M. ;
Wacker, Wynn K. ;
Davis, Cynthia E. ;
Shapiro, Michael D. ;
Ergun, David L. .
OBESITY, 2012, 20 (06) :1313-1318
[30]   Serum phosphate levels and mortality risk among people with chronic kidney disease [J].
Kestenbaum, B ;
Sampson, JN ;
Rudser, KD ;
Patterson, DJ ;
Seliger, SL ;
Young, B ;
Sherrard, DJ ;
Andress, DL .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (02) :520-528